AFT Pharmaceuticals Limited (AFP.AX) Comparison with companies in other sectors?

AFT Pharmaceuticals Limited has a share price of 104.87M. You can analyze AFT Pharmaceuticals Limited (AFP.AX) competitors across different market sectors through stock heatmaps.

What are AFP.AX's NET and operating margins?

AFT Pharmaceuticals Limited (AFP.AX) operating margin is around 0.08, and net profit margin is approximately 0.06 as of the latest reports.

In what way does AFP.AX's earnings per share (EPS) trend reflect its financial momentum?

AFT Pharmaceuticals Limited (AFP.AX) EPS is 0.10 (If EPS value is positive, then “signals consistent profit growth” if Negative then “signals consistent loss”). This metric is also critical in assessing valuation metrics like the P/E ratio for AFT Pharmaceuticals Limited is 24.50, and the company’s ability to reinvest or distribute profits.

What does a high ROE mean for AFT Pharmaceuticals Limited?

A high ROE suggests efficient use of shareholder equity to generate profit. It often signals strong management and profitability.

How do I know if AAPL is overvalued or undervalued?

Check valuation ratios for AFT Pharmaceuticals Limited like P/E which is 23.25, P/B which is 2.85, and PEG which is 1.06. Compare them with sector averages to evaluate if the stock is priced fairly.

AFT Pharmaceuticals Limited

AFP.AX•ASX

Healthcare

Drug Manufacturers - Specialty & Generic

A$2.45

A$0.05(2.08%)

AFT Pharmaceuticals Limited (AFP.AX) Fundamental Analysis: Financial Health, Valuation, and Key Ratios

Dive into Apple Inc.’s fundamentals including valuation ratios, profitability, efficiency metrics, and financial health. Use this data to assess long-term investment quality and compare it with sector benchmarks.

EPS (TTM)

$0.10

P/E Ratio

24.50

ROE

0.13%

Net Margin

0.06%

Key Financial Metrices

Valuation Metrics

4 metrics

Market CapTotal market value of outstanding shares

$256.92M

Shares OutstandingTotal number of shares issued

$104.87M

Book Value/ShareNet worth per share

$0.94

Revenue/ShareAnnual revenue per share

$2.009

Profitability Metrics

6 metrics

EPS (TTM)Earnings per share trailing twelve months

$0.1

Net MarginNet income as percentage of revenue

5.75%

Operating MarginOperating income as percentage of revenue

8.48%

ROEReturn on shareholders' equity

13.19%

ROAReturn on total assets

7.04%

ROCEReturn on capital employed

13.94%

Cash Flow Metrics

3 metrics

Free Cash Flow/ShareCash generated per share after capex

$0.12

Cash/ShareCash and equivalents per share

$0.11

FCF YieldFree cash flow as percentage of market cap

4.58%

Dividend Metrics

2 metrics

Dividend/ShareAnnual dividend payment per share

$0.01

Dividend YieldAnnual dividend as percentage of stock price

0.45%

Financial Ratios Analysis data is not available for AFP.AXFinancial Ratios Analysis details for AFP.AX are currently unavailable. We're actively monitoring for updates and will publish them as soon as they’re released. Please check back again shortly.

Sector Benchmarking data is not available for AFP.AXSector Benchmarking details for AFP.AX are currently unavailable. We're actively monitoring for updates and will publish them as soon as they’re released. Please check back again shortly.

Understanding Fundamental Analysis for AFT Pharmaceuticals Limited Investment Decisions

What is Fundamental Analysis?

Fundamental analysis is a method used to assess the intrinsic value of AFT Pharmaceuticals Limited. Using financial reports, management structure, competitive position, and market environment, investors can determine whether the stock is undervalued or overvalued. This analysis helps investors like you make more informed investment decisions, taking into account AFT Pharmaceuticals Limited's unique business strengths and challenges.

Key Financial Metrics for AFT Pharmaceuticals Limited

For AFT Pharmaceuticals Limited, essential financial indicators include EPS 0.10, PE 24.50, and ROE 0.13. These key ratios reveal insights into AFT Pharmaceuticals Limited's profitability, valuation, and operational health. Understanding these metrics enables you to compare AFT Pharmaceuticals Limited with its industry peers and decide whether it presents a viable investment opportunity.

Profitability and Operational Efficiency of AFT Pharmaceuticals Limited

Metrics like Net Margin 5.75% and ROA 7.04% shed light on how well AFT Pharmaceuticals Limited is generating profits. A high profitability ratio often indicates strong management and a solid business model, which are essential for long-term growth. These metrics are crucial in assessing whether AFT Pharmaceuticals Limited can sustain its operations and continue growing in the future.

Valuation and Market Position of AFT Pharmaceuticals Limited

Using ratios such as P/B Ratio 2.85 and PEG Ratio 1.06, investors can assess whether AFT Pharmaceuticals Limited is appropriately valued based on its financials and growth potential. These figures, combined with AFT Pharmaceuticals Limited's market capitalization, give insight into its competitive positioning and investor expectations, helping you make informed decisions on pricing and value.

Financial Health and Risk Assessment for AFT Pharmaceuticals Limited

Financial health indicators, such as Debt/Equity Ratio 0.31 and Cash Flow $0.12, provide a snapshot of AFT Pharmaceuticals Limited's ability to meet financial obligations and handle economic setbacks. A company with a strong balance sheet and solid cash flow, like AFT Pharmaceuticals Limited, is more likely to weather financial storms, making it a safer investment.

Long-Term Investment Strategy for AFT Pharmaceuticals Limited

Investing in AFT Pharmaceuticals Limited based on fundamental analysis emphasizes long-term business growth rather than short-term market trends. Investors looking at AFT Pharmaceuticals Limited focus on its solid financial performance, industry standing, and competitive advantages, all of which suggest sustainable growth and the potential for steady returns over time.

Fundamental Analysis FAQ

;